These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 15268972

  • 1. Effects of Lactobacillus helveticus fermented milk on bone cells in vitro.
    Narva M, Halleen J, Väänänen K, Korpela R.
    Life Sci; 2004 Aug 20; 75(14):1727-34. PubMed ID: 15268972
    [Abstract] [Full Text] [Related]

  • 2. Effects of bioactive peptide, valyl-prolyl-proline (VPP), and lactobacillus helveticus fermented milk containing VPP on bone loss in ovariectomized rats.
    Narva M, Rissanen J, Halleen J, Vapaatalo H, Väänänen K, Korpela R.
    Ann Nutr Metab; 2007 Aug 20; 51(1):65-74. PubMed ID: 17356257
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Short communication: Effects of Lactobacillus helveticus-fermented milk on the differentiation of cultured normal human epidermal keratinocytes.
    Baba H, Masuyama A, Takano T.
    J Dairy Sci; 2006 Jun 20; 89(6):2072-5. PubMed ID: 16702271
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Fermentation characteristics and angiotensin I-converting enzyme-inhibitory activity of Lactobacillus helveticus isolate H9 in cow milk, soy milk, and mare milk.
    Wang J, Li C, Xue J, Yang J, Zhang Q, Zhang H, Chen Y.
    J Dairy Sci; 2015 Jun 20; 98(6):3655-64. PubMed ID: 25892687
    [Abstract] [Full Text] [Related]

  • 10. Studies of the toxicological potential of tripeptides (L-valyl-L-prolyl-L-proline and L-isoleucyl-L-prolyl-L-proline): VI. Effects of Lactobacillus helveticus-fermented milk powder on fertility and reproductive performance of rats.
    Kurosaki T, Maeno M, Mennear JH, Bernard BK.
    Int J Toxicol; 2005 Jun 20; 24 Suppl 4():61-89. PubMed ID: 16419579
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Studies of the toxicological potential of tripeptides (L-valyl-L-prolyl-L-proline and L-isoleucyl-L-prolyl-L-proline): III. Single- and/or repeated-dose toxicity of tripeptides-containing Lactobacillus helveticus-fermented milk powder and casein hydrolysate in rats.
    Maeno M, Nakamura Y, Mennear JH, Bernard BK.
    Int J Toxicol; 2005 Jun 20; 24 Suppl 4():13-23. PubMed ID: 16419576
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.